Victory Capital Management Inc T2 Biosystems, Inc. Transaction History

Victory Capital Management Inc

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 01, 2022	BUY	$0.15 - $0.54 $84 - $305	566 Added 2.51%	23,159 $4,000
Q1 2022 May 04, 2022	SELL	$0.36 - $0.57 $210 - $333	-585 Reduced 2.52%	22,593 $8,000
Q4 2021 Feb 07, 2022	SELL	$0.46 - $0.94 $323 - $661	-704 Reduced 2.95%	23,178 $12,000
Q3 2021 Nov 02, 2021	BUY	$0.86 - $1.21 $1,011 - $1,422	1,176 Added 5.18%	23,882 $22,000
Q2 2021 Aug 03, 2021	SELL	$1.04 - $1.69 $384 - $625	-370 Reduced 1.6%	22,706 $27,000
Q1 2021 May 04, 2021	SELL	$1.32 - $3.79 $949 - $2,725	-719 Reduced 3.02%	23,076 $37,000
Q4 2020 Feb 01, 2021	BUY	$1.06 - $1.51 $1,288 - $1,836	1,216 Added 5.39%	23,795 $30,000
Q3 2020 Nov 09, 2020	BUY	$1.15 - $2.1 $4,074 - $7,440	3,543 Added 18.61%	22,579 $31,000
Q2 2020 Aug 07, 2020	BUY	$0.48 - $1.67 $1,739 - $6,050	3,623 Added 23.51%	19,036 $24,000
Q1 2020 May 04, 2020	BUY	$0.28 - $1.23 $2,509 - $11,024	8,963 Added 138.96%	15,413 $10,000
Q4 2019 Feb 04, 2020	BUY	$0.96 - $2.94 $790 - $2,419	823 Added 14.63%	6,450 $6,000
Q3 2019 Nov 12, 2019	BUY	$0.58 - $3.01 $3,263 - $16,937	5,627 New	5,627 $14,000

Ticker TTOO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 7,050,850
Market Cap $3.88M
Description
T2 Biosystems, Inc., an in vitro diagnostics company, develops diagnostic products and product candidates in the United States and internationally. Its technology enables detection of pathogens, biomarkers, and other abnormalities in various unpurified patient sample types, including whole blood, plasma, serum, saliva, sputum, cerebral spinal fl...

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

Stay updated on Victory Capital Management Inc with notifications on news.